In a diverse cohort of virologically suppressed women with HIV, long-acting cabotegravir and rilpivirine (CAB+RPV LA) maintained high rates of viral suppression with low virologic failure over a median...
A new study finds that electronic health record activity data are poor predictors of individual physician burnout but may help flag clinics where burnout risk is highest.
Researchers evaluated the safety and efficacy of dolutegravir plus lamivudine in treatment-naive individuals with HIV without baseline resistance testing.
A recent study examined how prior SARS-CoV-2 vaccination influences innate and adaptive immune responses in breakthrough infections, revealing distinct immune activation patterns.
This respiratory health update covers rising influenza deaths, the spread of new SARS-CoV-2 variants, shifting reinfection patterns, and cardiovascular risks in children
In this respiratory diseases roundup, researchers examine COVID-19 protection, hospitalization rates, long COVID predictors, and rare disease mortality risks.
A randomized trial comparing influenza vaccines over two seasons found that recombinant vaccines showed stronger immune responses to A/H3N2 strains compared with egg-based and cell culture-based vaccines. ...
The US Preventive Services Task Force assessed the benefits and harms of osteoporosis screening in adults aged 40 years or older without a known diagnosis of osteoporosis or history of fragility fractures.
...
In this respiratory disease roundup, experts examine the rising cases of human metapneumovirus in China, new research on COVID-19’s long-term effects on kidney function, the effectiveness of...
The FDA has approved suzetrigine 50 milligram oral tablets for moderate to severe acute pain in adults. The drug acts on the peripheral nervous system before pain signals can reach the brain, eliminating...
